Advertisement

Biomanufacturing: history and perspective

  • Yi-Heng Percival Zhang
  • Jibin Sun
  • Yanhe Ma
Bioenergy/Biofuels/Biochemicals - Review

Abstract

Biomanufacturing is a type of manufacturing that utilizes biological systems (e.g., living microorganisms, resting cells, animal cells, plant cells, tissues, enzymes, or in vitro synthetic (enzymatic) systems) to produce commercially important biomolecules for use in the agricultural, food, material, energy, and pharmaceutical industries. History of biomanufacturing could be classified into the three revolutions in terms of respective product types (mainly), production platforms, and research technologies. Biomanufacturing 1.0 focuses on the production of primary metabolites (e.g., butanol, acetone, ethanol, citric acid) by using mono-culture fermentation; biomanufacturing 2.0 focuses on the production of secondary metabolites (e.g., penicillin, streptomycin) by using a dedicated mutant and aerobic submerged liquid fermentation; and biomanufacturing 3.0 focuses on the production of large-size biomolecules—proteins and enzymes (e.g., erythropoietin, insulin, growth hormone, amylase, DNA polymerase) by using recombinant DNA technology and advanced cell culture. Biomanufacturing 4.0 could focus on new products, for example, human tissues or cells made by regenerative medicine, artificial starch made by in vitro synthetic biosystems, isobutanol fermented by metabolic engineering, and synthetic biology-driven microorganisms, as well as exiting products produced by far better approaches. Biomanufacturing 4.0 would help address some of the most important challenges of humankind, such as food security, energy security and sustainability, water crisis, climate change, health issues, and conflict related to the energy, food, and water nexus.

Keywords

Advanced biomanufacturing Biomanufacturing 4.0 Bioeconomy In vitro synthetic biosystem Metabolic engineering and synthetic biology Sustainability revolution 

Notes

Acknowledgements

This paper could not have been written without the support of the Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, China and the Biological System Engineering Department, Virginia Polytechnic Institute and State University, Virginia, USA. Also, it is partially supported by the Department of Energy, Office of Energy Efficiency and Renewable Energy, Fuel Cell Technologies Office under Award Number DE-EE0006968 to YPZ. Also, authors JBS and YHM were partially supported by Tianjin Municipal Science and Technology Commission for the financial supports of 13ZCZDSY04900 and 11ZCZDSY08400. Funding to YPZ for this work was partially supported by the Virginia Agricultural Experiment Station and the Hatch Program of the National Institute of Food and Agriculture, U.S. Department of Agriculture.

References

  1. 1.
    Afeyan NB, Cooney CL (2006) Professor Daniel I.C. Wang: a legacy of education, innovation, publication, and leadership. Biotechnol Bioeng 95(2):206–217CrossRefPubMedGoogle Scholar
  2. 2.
    Atsumi S, Hanai T, Liao JC (2008) Non-fermentative pathways for synthesis of branched-chain higher alcohols as biofuels. Nature 451(7174):86–89CrossRefPubMedGoogle Scholar
  3. 3.
    Benner SA, Sismour AM (2005) Synthetic biology. Nat Rev Gen 6(7):533–543CrossRefGoogle Scholar
  4. 4.
    Bornscheuer UT, Huisman GW, Kazlauskas RJ, Lutz S, Moore JC, Robins K (2012) Engineering the third wave of biocatalysis. Nature 485(7397):185–194CrossRefPubMedGoogle Scholar
  5. 5.
    Chen H-G, Zhang Y-HP (2015) New biorefineries and sustainable agriculture: increased food, biofuels, and ecosystem security. Renew Sust Energy Rev 47:117–132CrossRefGoogle Scholar
  6. 6.
    Davies HM (2010) Commercialization of whole-plant systems for biomanufacturing of protein products: evolution and prospects. Plant Biotechnol J 8(8):845–861CrossRefPubMedGoogle Scholar
  7. 7.
    Demain AL (2004) Pickles, pectin, and penicillin. Annu Rev Microbiol 58:1–42CrossRefPubMedGoogle Scholar
  8. 8.
    Demain AL (2007) REVIEWS: the business of biotechnology. Ind Biotechnol 3(3):269–283CrossRefGoogle Scholar
  9. 9.
    Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27(3):297–306CrossRefPubMedGoogle Scholar
  10. 10.
    Department of Economic and Social Affairs, United Nations (2013) World economic and social survey 2013—sustainable development challengesGoogle Scholar
  11. 11.
    Dudley QM, Karim AS, Jewett MC (2015) Cell-free metabolic engineering: biomanufacturing beyond the cell. Biotechnol J 10:69–82CrossRefPubMedGoogle Scholar
  12. 12.
    Endy D (2005) Foundations for engineering biology. Nature 438(7067):449–453CrossRefPubMedGoogle Scholar
  13. 13.
    Fessner W-D (2015) Systems Biocatalysis: development and engineering of cell-free “artificial metabolisms” for preparative multi-enzymatic synthesis. New Biotechnol 32:658–664CrossRefGoogle Scholar
  14. 14.
    Fleet GH (2008) Wine yeasts for the future. FEMS Yeast Res 8(7):979–995CrossRefPubMedGoogle Scholar
  15. 15.
    Forster AC, Church GM (2007) Synthetic biology projects in vitro. Genome Res 17(1):1–6CrossRefPubMedGoogle Scholar
  16. 16.
    Galanie S, Thodey K, Trenchard IJ, Filsinger Interrante M, Smolke CD (2015) Complete biosynthesis of opioids in yeast. Science 349:1095–1100CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Goerke AR, Loening AM, Gambhir SS, Swartz JR (2008) Cell-free metabolic engineering promotes high-level production of bioactive Gaussia princeps luciferase. Metab Eng 10(3–4):187–200CrossRefPubMedGoogle Scholar
  18. 18.
    Goerke AR, Swartz JR (2008) Development of cell-free protein synthesis platforms for disulfide bonded proteins. Biotechnol Bioeng 99(2):351–367CrossRefPubMedGoogle Scholar
  19. 19.
    Goto M, Akai K, Murakami A, Hashimoto C, Tsuda E, Ueda M, Kawanishi G, Takahashi N, Ishimoto A, Chiba H et al (1988) Production of recombinant human erythropoietin in mammalian cells: host-cell dependency of the biological activity of the cloned glycoprotein. Nat Biotechnol 6(1):67–71CrossRefGoogle Scholar
  20. 20.
    Gottschalk U, Brorson K, Shukla AA (2012) The need for innovation in biomanufacturing. Nat Biotechnol 30(6):489–492CrossRefPubMedGoogle Scholar
  21. 21.
    Guterl J-K, Garbe D, Carsten J, Steffler F, Sommer B, Reiße S, Philipp A, Haack M, Rühmann B, Kettling U et al (2012) Cell-free metabolic engineering—production of chemicals via minimized reaction cascades. ChemSusChem 5:2165–2172CrossRefPubMedGoogle Scholar
  22. 22.
    Henry RJ (1943) The mode of action of sulfonamides. Bacteriol Rev 7(4):175–262PubMedPubMedCentralGoogle Scholar
  23. 23.
    Hu Q-Y, Berti F, Adamo R (2016) Towards the next generation of biomedicines by site-selective conjugation. Chem Soc Rev 45:1691–1719CrossRefPubMedGoogle Scholar
  24. 24.
    Humphrey AE (1991) Elmer L. Gaden, Jr., father of biochemical engineering. Biotechnol Bioeng 37(11):995–997CrossRefPubMedGoogle Scholar
  25. 25.
    Jewett MC, Calhoun KA, Voloshin A, Wuu JJ, Swartz JR (2008) An integrated cell-free metabolic platform for protein production and synthetic biology. Mol Syst Biol 4:57CrossRefGoogle Scholar
  26. 26.
    Kanter G, Yang J, Voloshin A, Levy S, Swartz JR, Levy R (2007) Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines. Blood 109(8):3393–3399CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Karim AS, Jewett MC (2016) A cell-free framework for rapid biosynthetic pathway prototyping and enzyme discovery. Metab Eng 36:116–126CrossRefPubMedGoogle Scholar
  28. 28.
    Kim E-J, Adams M, Wu C-H, Zhang YHP (2016) Exceptionally high rates of biological hydrogen production by biomimetic in vitro synthetic enzymatic pathways. Chem A Eur J 22:16047–16051Google Scholar
  29. 29.
    Kim J-E, Zhang Y-HP (2016) Biosynthesis of d-xylulose 5-phosphate from d-xylose and polyphosphate through a minimized two-enzyme cascade. Biotechnol Bioeng 113:275–282CrossRefPubMedGoogle Scholar
  30. 30.
    Korman TP, Sahachartsiri B, Li D, Vinokur JM, Eisenberg D, Bowie JU (2014) A synthetic biochemistry system for the in vitro production of isoprene from glycolysis intermediates. Protein Sci 25:576–585CrossRefGoogle Scholar
  31. 31.
    Kwok R (2010) Five hard truths for synthetic biology. Nature 463:288–290CrossRefPubMedGoogle Scholar
  32. 32.
    Lan EI, Liao JC (2013) Microbial synthesis of n-butanol, isobutanol, and other higher alcohols from diverse resources. Bioresour Technol 135:339–349CrossRefPubMedGoogle Scholar
  33. 33.
    Lee SY (1996) High cell-density culture of Escherichia coli. Trends Biotechnol 14(3):98–105CrossRefPubMedGoogle Scholar
  34. 34.
    Liese A, Hilterhaus L (2013) Evaluation of immobilized enzymes for industrial applications. Chem Soc Rev 42:6236–6249CrossRefPubMedGoogle Scholar
  35. 35.
    Mason C, Dunnill P (2007) A brief definition of regenerative medicine. Regen Med 3(1):1–5CrossRefGoogle Scholar
  36. 36.
    McGovern PE, Zhang J, Tang J, Zhang Z, Hall GR, Moreau RA, Nuñez A, Butrym ED, Richards MP, C-s Wang et al (2004) Fermented beverages of pre- and proto-historic China. Proc Nat Acad Sci USA 101(51):17593–17598CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Michels P, Rosazza J (2009) The evolution of microbial transformations for industrial applications. SIM News 2009(March/April):36–52Google Scholar
  38. 38.
    Moustafa HMA, Kim E-J, Zhu Z, Wu C-H, Zaghloul TI, Adams MWW, Zhang YHP (2016) Water splitting for high-yield hydrogen production energized by biomass xylooligosaccharides catalyzed by an enzyme cocktail. ChemCatChem. doi: 10.1002/cctc.201600772
  39. 39.
    Myung S, Rollin J, You C, Sun F, Chandrayan S, Adams MWW, Zhang Y-HP (2014) In vitro metabolic engineering of hydrogen production at theoretical yield from sucrose. Metab Eng 24(1):70–77CrossRefPubMedGoogle Scholar
  40. 40.
    Myung S, Zhang X-Z, Zhang Y-HP (2011) Ultra-stable phosphoglucose isomerase through immobilization of cellulose-binding module-tagged thermophilic enzyme on low-cost high-capacity cellulosic adsorbent. Biotechnol Prog 27:969–975CrossRefPubMedGoogle Scholar
  41. 41.
    Opgenorth PH, Korman TP, Bowie JU (2014) A synthetic biochemistry molecular purge valve module that maintains redox balance. Nat Commun 5:4113CrossRefPubMedGoogle Scholar
  42. 42.
    Opgenorth PH, Korman TP, Bowie JU (2016) A synthetic biochemistry module for production of bio-based chemicals from glucose. Nat Chem Biol 12:393–395CrossRefPubMedGoogle Scholar
  43. 43.
    Paddon CJ, Keasling JD (2014) Semi-synthetic artemisinin: a model for the use of synthetic biology in pharmaceutical development. Nat Rev Microbiol 12(5):355–367CrossRefPubMedGoogle Scholar
  44. 44.
    Qi P, You C, Zhang YHP (2014) One-pot enzymatic conversion of sucrose to synthetic amylose by using enzyme cascades. ACS Catal 4:1311–1317CrossRefGoogle Scholar
  45. 45.
    Renata H, Wang ZJ, Arnold FH (2015) Expanding the enzyme universe: accessing non-natural reactions by mechanism-guided directed evolution. Angew Chem Int Ed 54(11):3351–3367CrossRefGoogle Scholar
  46. 46.
    Rieckenberg F, Ardao I, Rujananon R, Zeng A-P (2014) Cell-free synthesis of 1,3-propanediol from glycerol with a high yield. Eng Life Sci 14:380–386CrossRefGoogle Scholar
  47. 47.
    Ro D-K, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J et al (2006) Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440(7086):940–943CrossRefPubMedGoogle Scholar
  48. 48.
    Rollin JA, Martin del Campo J, Myung S, Sun F, You C, Bakovic A, Castro R, Chandrayan SK, Wu C-H, Adams MWW et al (2015) High-yield hydrogen production from biomass by in vitro metabolic engineering: mixed sugars coutilization and kinetic modeling. Proc Nat Acad Sci USA 112:4964–4969CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Sakai H, Nakagawa T, Tokita Y, Hatazawa T, Ikeda T, Tsujimura S, Kano K (2009) A high-power glucose/oxygen biofuel cell operating under quiescent conditions. Energy Environ Sci 2:133–138CrossRefGoogle Scholar
  50. 50.
    Sano C (2009) History of glutamate production. Am J Clin Nutr 90(3):728S–732SCrossRefPubMedGoogle Scholar
  51. 51.
    Satoh Y, Tajima K, Tannai H, Munekata M (2003) Enzyme-catalyzed poly(3-hydroxybutyrate) synthesis from acetate with CoA recycling and NADPH regeneration in vitro. J Biosci Bioeng 95(4):335–341CrossRefPubMedGoogle Scholar
  52. 52.
    Sattler JH, Fuchs M, Mutti FG, Grischek B, Engel P, Pfeffer J, Woodley JM, Kroutil W (2014) Introducing an In Situ Capping Strategy in Systems Biocatalysis To Access 6-Aminohexanoic acid. Angew Chem Int Ed n/a–n/aGoogle Scholar
  53. 53.
    Schwab K (2016) The fourth industrial revolution. World Economic Forum, GenevaGoogle Scholar
  54. 54.
    Sheldon RA, van Pelt S (2013) Enzyme immobilisation in biocatalysis: why, what and how. Chem Soc Rev 42(15):6223–6235CrossRefPubMedGoogle Scholar
  55. 55.
    Siegel JB, Smith AL, Poust S, Wargacki AJ, Bar-Even A, Louw C, Shen BW, Eiben CB, Tran HM, Noor E et al (2015) Computational protein design enables a novel one-carbon assimilation pathway. Proc Nat Acad Sci USA 112(12):3704–3709PubMedPubMedCentralGoogle Scholar
  56. 56.
    Siegfried T (2005) In praise of hard questions. Science 309(5731):76–77CrossRefPubMedGoogle Scholar
  57. 57.
    Sochaj AM, Świderska KW, Otlewski J (2015) Current methods for the synthesis of homogeneous antibody–drug conjugates. Biotechnol Adv 33(6, Part 1):775–784CrossRefPubMedGoogle Scholar
  58. 58.
    Stephanopoulos G (2012) Synthetic biology and metabolic engineering. ACS Synth Biol 1:514–525CrossRefPubMedGoogle Scholar
  59. 59.
    Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872CrossRefPubMedGoogle Scholar
  60. 60.
    Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4):663–676CrossRefPubMedGoogle Scholar
  61. 61.
    Tessaro D, Pollegioni L, Piubelli L, D’Arrigo P, Servi S (2015) Systems biocatalysis: an artificial metabolism for interconversion of functional groups. ACS Catal 5:1604–1608Google Scholar
  62. 62.
    Vasic-Racki D (2006) History of industrial biotransformations—dreams and realities. In: Liese A, Seebald S, Wandrey C (eds) Industrial biotransformations. Wiley-VCH,KGaA, Weinheim, pp 1–37CrossRefGoogle Scholar
  63. 63.
    Wang Y, Huang W, Sathitsuksanoh N, Zhu Z, Zhang Y-HP (2011) Biohydrogenation from biomass sugar mediated by in vitro synthetic enzymatic pathways. Chem Biol 18:372–380CrossRefPubMedGoogle Scholar
  64. 64.
    Wang Y, Zhang Y-HP (2009) Cell-free protein synthesis energized by slowly-metabolized maltodextrin. BMC Biotechnol 9:58CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Ye X, Honda K, Sakai T, Okano K, Omasa T, Hirota R, Kuroda A, Ohtake H (2012) Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway. Microb Cell Fact 11(1):120CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Ye X, Zhang C, Zhang Y-HP (2012) Engineering a large protein by combined rational and random approaches: stabilizing the Clostridium thermocellum cellobiose phosphorylase. Mol BioSyst 8:1815–1823CrossRefPubMedGoogle Scholar
  67. 67.
    You C, Chen H, Myung S, Sathitsuksanoh N, Ma H, Zhang X-Z, Li J, Zhang Y-HP (2013) Enzymatic transformation of nonfood biomass to starch. Proc Nat Acad Sci USA 110:7182–7187CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Zhang Y-HP (2010) Production of biocommodities and bioelectricity by cell-free synthetic enzymatic pathway biotransformations: challenges and opportunities. Biotechnol Bioeng 105:663–677PubMedGoogle Scholar
  69. 69.
    Zhang Y-HP (2011) Simpler is better: high-yield and potential low-cost biofuels production through cell-free synthetic pathway biotransformation (SyPaB). ACS Catal 1:998–1009CrossRefGoogle Scholar
  70. 70.
    Zhang Y-HP (2013) Next generation biorefineries will solve the food, biofuels, and environmental trilemma in the energy-food-water nexus. Energy Sci Eng 1:27–41CrossRefGoogle Scholar
  71. 71.
    Zhang Y-HP (2015) Production of biofuels and biochemicals by in vitro synthetic biosystems: opportunities and challenges. Biotechnol Adv 33:1467–1483CrossRefPubMedGoogle Scholar
  72. 72.
    Zhang Y-HP, Evans BR, Mielenz JR, Hopkins RC, Adams MWW (2007) High-yield hydrogen production from starch and water by a synthetic enzymatic pathway. PLoS One 2(5):e456CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Zhang Y-HP, Himmel M, Mielenz JR (2006) Outlook for cellulase improvement: screening and selection strategies. Biotechnol Adv 24(5):452–481CrossRefGoogle Scholar
  74. 74.
    Zhang Y-HP, Huang W-D (2012) Constructing the electricity-carbohydrate-hydrogen cycle for a sustainability revolution. Trends Biotechnol 30(6):301–306CrossRefPubMedGoogle Scholar
  75. 75.
    Zhang Y-HP, Sun J-B, Zhong J-J (2010) Biofuel production by in vitro synthetic pathway transformation. Curr Opin Biotechnol 21:663–669CrossRefPubMedGoogle Scholar
  76. 76.
    Zhou W, You C, Ma H, Ma Y, Zhang Y-HP (2016) One-pot biosynthesis of high-concentration α-glucose 1-phosphate from starch by sequential addition of three hyperthermophilic enzymes. J Agric Food Chem 64:1777–1783CrossRefPubMedGoogle Scholar
  77. 77.
    Zhu Z-G, Kin Tam T, Sun F, You C, Zhang Y-HP (2014) A high-energy-density sugar biobattery based on a synthetic enzymatic pathway. Nat Commun 5:3026PubMedGoogle Scholar

Copyright information

© Society for Industrial Microbiology and Biotechnology 2016

Authors and Affiliations

  1. 1.Tianjin Institute of Industrial BiotechnologyChinese Academy of ScienceTianjinChina
  2. 2.Biological Systems Engineering DepartmentVirginia TechBlacksburgUSA

Personalised recommendations